GALT - Galectin Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development11,72115,32513,114
Selling General and Administrative4,5266,1566,965
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-16,247-21,481-20,079
Income from Continuing Operations
Total Other Income/Expenses Net244552
Earnings Before Interest and Taxes-16,223-21,436-20,027
Interest Expense121212
Income Before Tax-16,235-21,436-20,027
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-16,235-21,436-20,027
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-16,235-21,436-20,027
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-17,467-22,350-21,124